ArticleCellular oncology (Dordrecht, Netherlands)2026
ACTG1 promotes breast cancer aggressiveness and confers ribociclib resistance by deubiquitinating HSPA8 through UCHL3.
Quhui Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.